# Avazzia-University of Texas Southwestern Medical Center-Tennant Biomodulator® PRO Perfusion Study

> **NCT03843307** · NA · TERMINATED · sponsor: **Avazzia, Inc** · enrollment: 6 (actual)

## Conditions studied

- Perfusion; Complications
- Wound; Foot

## Interventions

- **DEVICE:** Avazzia Tennant Biomodulator® PRO

## Key facts

- **NCT ID:** NCT03843307
- **Lead sponsor:** Avazzia, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-24
- **Primary completion:** 2021-04-12
- **Final completion:** 2021-04-12
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Due to difficulties with enrollment which were complicated by pauses to clinical research from COVID, The University of Texas Southwestern has decided not to pursue the continuation of this study.
- **Last updated:** 2021-08-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03843307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03843307, "Avazzia-University of Texas Southwestern Medical Center-Tennant Biomodulator® PRO Perfusion Study". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03843307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*